NCT06424444: An ongoing trial by Aldeyra Therapeutics, Inc.
This trial is completed, but has been granted a delay in reporting its results.
It must report results 1 year, 10 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06424444 |
|---|---|
| Title | A Multicenter, Phase 3, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Environment Exposure Clinical Trial to Assess the Efficacy and Safety of 0.25% Reproxalap Ophthalmic Solution Compared to Vehicle in Subjects With Dry Eye Disease |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | April 29, 2024 |
| Completion date | Nov. 3, 2024 |
| Required reporting date | Nov. 3, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |